Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
MRNA on Nasdaq
Ph.D. Noubar B. Afeyan - trading volume in the past year for Moderna, Inc.
Holdings reported by Ph.D. Noubar B. Afeyan for Moderna, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3,880,328 |
$103,643,560 |
$26.71 |
11 Dec 2025 |
By Flagship Ventures Fund IV, L.P. |
|
|
| Common Stock |
2,224,015 |
$59,403,440 |
$26.71 |
11 Dec 2025 |
Direct |
|
|
| Common Stock |
747,897 |
$19,976,328 |
$26.71 |
11 Dec 2025 |
By Flagship Ventures Fund IV-Rx, L.P. |
|
|
| Common Stock |
3,924 |
$115,699 |
$29.48 |
11 Dec 2025 |
By Flagship Pioneering, Inc. |
|
|
| Stock Option (Right to Buy) |
25,512 |
|
|
30 Apr 2025 |
Direct |
Common Stock |
|
| Stock Option (Right to Buy) |
0 |
|
|
11 Dec 2025 |
By Flagship Pioneering, Inc. |
Common Stock |
|
Transactions reported by Ph.D. Noubar B. Afeyan for Moderna, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.